Priority Dispute Is Not Carte Blanche to Challenge Same Patent with Multiple IPR Petitions

Apr 8, 2020

Reading Time : 2 min

The petitioner concurrently filed two IPR petitions challenging the same claims of a patent. In one petition, the petitioner challenged the claims with prior art that predated the filing date of the patent’s provisional application. In the other petition, the petitioner challenged the claim of priority to the provisional application and asserted prior art postdating the filing date of the provisional application. According to the petitioner, “[d]ue to the large number of claims and the volume of discussion on the priority deficiencies, these grounds could not be presented in a single filing.”

The Board instituted trial on the petition that did not challenge the priority date. The Board denied the other petition under 35 U.S.C. § 314(a) and found that the petitioner had failed to demonstrate the need for more than one petition to challenge the same patent claims.

In exercising its discretion, the Board first noted that the Trial Practice Guide (the “Guide”) states that “a substantial majority of patents have been challenged with a single petition.” And although, as the petitioner argued, the Guide expressly contemplates that multiple petitions directed to the same patent may be appropriate where “there is a dispute about priority date requiring arguments under multiple prior art references,” the Guide further instructs that “this should be rare.” In view of the Guide’s instruction, the Board explained that a petitioner is not automatically entitled to multiple reviews of the same patent claims whenever a priority issue arises. In this instance, the Board determined that the petitioner’s failure to adequately explain how this was one of those “rare” circumstances requiring the filing of two petitions weighed against institution.

The Board found the petitioner’s additional arguments equally unpersuasive to justify two petitions. Specifically, the Board held that the petitioner’s assertion that the petitions present “alternative arguments” that are “not cumulative challenges” did not provide a sufficient explanation of the differences between the petitions or the reasons why the Board should institute additional petitions if it identifies one that meets the institution requirements. The Board also rejected the argument that the large number of claims and volume of discussion on the priority deficiencies warranted two petitions. The Board determined that the 18 challenged claims was “not a significantly large number of claims to address in a single petition,” as evidenced by the fact that the petitioner was able to assert multiple grounds against all 18 claims in the instituted proceeding. The Board also found that, regardless of the alleged volume of discussion on priority deficiencies, the petitioner still failed to explain adequately why, if the Board institutes review on a petition where priority is not an issue, a second review that involves a priority dispute is necessary.

Practice Tip: When filing more than one inter partes review petition to address a dispute about the priority date of challenged claims, a petitioner should explain: (1) the differences between the petitions, (2) why the issues addressed by the different petitions are material and (3) why the Board should exercise its discretion to institute additional petitions if it identifies one petition that satisfies the institution standard. The petitioner should also explain how the circumstances surrounding its challenges, including a priority dispute, are “rare” and require multiple petitions.

Square, Inc., v. 4361423 Canada Inc., IPR2019-01626, Paper 14 (PTAB March 30, 2020)

Share This Insight

Previous Entries

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

IP Newsflash

April 9, 2026

In the April 1, 2026 edition of the Official Gazette, the U.S. Patent and Trademark Office announced a new procedural framework that permits patent owners to submit a limited, early response to a request for ex parte reexamination.

...

Read More

IP Newsflash

March 12, 2026

The Northern District of Illinois recently dismissed a complaint without prejudice for failing to plausibly allege patent infringement. The court found that the allegations of direct infringement were insufficiently pled where the images of the accused product included in the complaint did not appear to show a particular necessary element of the claims.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.